THYROCYTES EXPRESS INFLAMMATORY MEDIATORS

甲状腺细胞表达炎症介质

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Graves' disease is a common autoimmunine disease. Patients who have this disease are hyperthyroid and can develop a thyroid goiter, ophthalmopathy and/or dermopathy. We believe that antibodies and other factors (IL-16) present in the serum of patients with Graves' disease are important mediators of the inflammatory process, which characterizes the tissues affected by this disease. Some patients with Graves' disease have elevated levels of the cytokine IL-16 in their blood. We propose to measure and follow for 48 months, IL-16 levels in the blood of patients with Graves' disease and attempt to correlate these levels with the clinical severity and progression (for 48 months) of Graves' disease. IL-16 levels will also be measured in normal control subjects. Antibodies will be extracted from the blood samples donated by the study patients and used in cell culture experiments with thyroid cells. These experiments will 1) investigate the pathogenesis of thyroid inflammation and 2) identify potential therapeutic targets for interrupting the processes, which lead to the development of Graves' disease.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 Graves病是一种常见的自身免疫性疾病。患有这种疾病的患者是甲状腺功能亢进症,并可能发展为甲状腺肿,眼病和/或皮肤病。我们认为,抗体和其他因素(IL-16)存在于Graves病患者的血清中是炎症过程的重要介质,其特征是受这种疾病影响的组织。一些格雷夫斯病患者血液中细胞因子IL-16水平升高。 我们建议测量并随访48个月,Graves病患者血液中的IL-16水平,并试图将这些水平与Graves病的临床严重程度和进展(48个月)相关联。还将在正常对照受试者中测量IL-16水平。将从研究患者捐献的血液样本中提取抗体,并用于甲状腺细胞的细胞培养实验。这些实验将1)研究甲状腺炎症的发病机制,2)确定潜在的治疗靶点,以中断导致格雷夫斯病发展的过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW G GIANOUKAKIS其他文献

ANDREW G GIANOUKAKIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW G GIANOUKAKIS', 18)}}的其他基金

THYROCYTES EXPRESS INFLAMMATORY MEDIATORS
甲状腺细胞表达炎症介质
  • 批准号:
    8174473
  • 财政年份:
    2009
  • 资助金额:
    $ 8.17万
  • 项目类别:
THYROCYTES EXPRESS INFLAMMATORY MEDIATORS
甲状腺细胞表达炎症介质
  • 批准号:
    7952277
  • 财政年份:
    2008
  • 资助金额:
    $ 8.17万
  • 项目类别:
THYROCYTES EXPRESS INFLAMMATORY MEDIATORS
甲状腺细胞表达炎症介质
  • 批准号:
    7952220
  • 财政年份:
    2008
  • 资助金额:
    $ 8.17万
  • 项目类别:
THYROCYTES EXPRESS INFLAMMATORY MEDIATORS
甲状腺细胞表达炎症介质
  • 批准号:
    7376062
  • 财政年份:
    2005
  • 资助金额:
    $ 8.17万
  • 项目类别:
THYROCYTES EXPRESS INFLAMMATORY MEDIATORS
甲状腺细胞表达炎症介质
  • 批准号:
    7206381
  • 财政年份:
    2004
  • 资助金额:
    $ 8.17万
  • 项目类别:
Thyrocytes Express Inflammatory Mediators
甲状腺细胞表达炎症介质
  • 批准号:
    7042131
  • 财政年份:
    2003
  • 资助金额:
    $ 8.17万
  • 项目类别:
Thyrocytes Express Inflammatory Mediators
甲状腺细胞表达炎症介质
  • 批准号:
    7071693
  • 财政年份:
    2002
  • 资助金额:
    $ 8.17万
  • 项目类别:
Thyrocytes Express Inflammatory Mediators
甲状腺细胞表达炎症介质
  • 批准号:
    6898790
  • 财政年份:
    2002
  • 资助金额:
    $ 8.17万
  • 项目类别:
Thyrocytes Express Inflammatory Mediators
甲状腺细胞表达炎症介质
  • 批准号:
    6605770
  • 财政年份:
    2002
  • 资助金额:
    $ 8.17万
  • 项目类别:
Thyrocytes Express Inflammatory Mediators
甲状腺细胞表达炎症介质
  • 批准号:
    6507797
  • 财政年份:
    2002
  • 资助金额:
    $ 8.17万
  • 项目类别:

相似海外基金

Fine-tuning blood cell development: Using antibodies as surrogate cytokines to modify receptor activation and signalling in haematopoiesis
微调血细胞发育:使用抗体作为替代细胞因子来改变造血过程中的受体激活和信号传导
  • 批准号:
    2752707
  • 财政年份:
    2022
  • 资助金额:
    $ 8.17万
  • 项目类别:
    Studentship
Identifying targeting antibodies in an in vitro model of the human blood-brain barrier during ischemic stroke
在缺血性中风期间人血脑屏障的体外模型中识别靶向抗体
  • 批准号:
    10761258
  • 财政年份:
    2022
  • 资助金额:
    $ 8.17万
  • 项目类别:
Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters
利用葡萄糖转运蛋白的生物学特性开发血脑屏障跨越抗体
  • 批准号:
    21K18268
  • 财政年份:
    2021
  • 资助金额:
    $ 8.17万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Discovery of Novel Blood-Brain Barrier Targeting Antibodies for the Treatment of Alzheimer's Disease
发现用于治疗阿尔茨海默病的新型血脑屏障靶向抗体
  • 批准号:
    10254514
  • 财政年份:
    2021
  • 资助金额:
    $ 8.17万
  • 项目类别:
Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis - A prospective evaluation
NT5c1A 抗体对散发性包涵体肌炎疾病进展、临床表型以及血液和肌肉生物标志物的影响 - 前瞻性评估
  • 批准号:
    10596154
  • 财政年份:
    2021
  • 资助金额:
    $ 8.17万
  • 项目类别:
Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis - A prospective evaluation
NT5c1A 抗体对散发性包涵体肌炎疾病进展、临床表型以及血液和肌肉生物标志物的影响 - 前瞻性评估
  • 批准号:
    10381454
  • 财政年份:
    2021
  • 资助金额:
    $ 8.17万
  • 项目类别:
Development of localized surface plasmon resonance biosensor for COVID-19 antibodies in blood
开发血液中 COVID-19 抗体的局部表面等离子共振生物传感器
  • 批准号:
    551057-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 8.17万
  • 项目类别:
    Alliance Grants
Development of high throughput, inexpensive and scalable testing to detect SARS-CoV-2 antibodies using home blood collection kits and a fully automated ELISA antibody assay
开发高通量、廉价且可扩展的测试,使用家庭采血套件和全自动 ELISA 抗体测定来检测 SARS-CoV-2 抗体
  • 批准号:
    429367
  • 财政年份:
    2020
  • 资助金额:
    $ 8.17万
  • 项目类别:
    Operating Grants
Study on antigen-positive red blood cells transfusion for the patients who have corresponding irregular RBC antibodies
具有相应不规则红细胞抗体的患者抗原阳性红细胞输注的研究
  • 批准号:
    19K07935
  • 财政年份:
    2019
  • 资助金额:
    $ 8.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Qualitative study of Neutralizing and Epitope-specific Antibodies against RSV in Pairs of Maternal Blood and Cord Blood to Overcome RSV infection
母血和脐带血中 RSV 中和抗体和表位特异性抗体克服 RSV 感染的定性研究
  • 批准号:
    18K07794
  • 财政年份:
    2018
  • 资助金额:
    $ 8.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了